S
Soleno Therapeutics D
D
SLNO
79.205
USD
-1.05
(-1.30%)
مغلق
حجم التداول
19,223
الربح لكل سهم
-3
العائد الربحي
-
P/E
-17
حجم السوق
3,991,451,305
الأخبار المقالات
العنوان: Soleno Therapeutics
القطاع: Healthcare
الصناعة: Biotechnology
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulationof a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.